Wild Immunity research about immune checkpoint molecules is published in Frontiers in Immunology

This new publication shows that the key immune checkpoint molecule PD-L1 (aka B7-H1) is upregulated on devil facial tumour cells in response to interferon-gamma (IFNg). This could be an important immune evasion mechanism used by the tumour to shut off anti-tumour responses by T cells and NK cells.